Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

EMA committee recommends approval of obinutuzumab

May 26, 2014

GSK and Genmab report topline data from pivotal head-to-head study of ofatumumab

May 21, 2014

MOR-208 receives FDA and EMA orphan drug designations

May 21, 2014

ADC Therapeutics and MedImmune to advance ADCT-401 into clinic

May 21, 2014

NeoStem signs licensing agreement with Cellular Biomedicine for DC-TC

May 20, 2014

Helix BioPharma seeks Canadian clearance for study of L-DOS47

May 15, 2014

FDA grants nivolumab breakthrough therapy designation for Hodgkin's lymphoma

May 15, 2014

FDA grants fast track status to Prima BioMed's CVac program

May 12, 2014

Cellmid selects lead anti-MK antibody in oncology

May 12, 2014

PSMA MAb [177Lu]J-591 tested for treatment of metastatic solid tumors

May 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...